SMARCA2 levels were decreased by 1.07-fold in HT group in comparison to control group, however without reaching statistical significance (95% CI: −19 to 0.67, p = 0.5876), whereas we observe significant increase in apoptosis by 4.11-fold in HT group (95% CI: 2.9 to 4.32, p < 0.0001) (Fig. 3B, Supplementary Fig. 4). Here, SMARCA2 is linked to hematocrit.